Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-OX40L (Clone R4930 (Oxelumab))
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-CD33 (Clone hP67.6 (Gemtuzumab))
Applications | FC, IF |
Reactivities | Human |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Recombinant Anti-Beta-galactosidase (Clone 13R4)
Applications | FC, WB |
Reactivities | Escherichia coli |
Anti-TIGIT [AET2010], Human IgG1, lambda
Applications | ELISA, FC |
Reactivities | Human |
Recombinant Anti-PD-L1 (Clone 332M7)
Applications | Bl, FC |
Reactivities | Human, Mouse, Monkey |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3018 (03-018))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3018 (03-018))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
Applications | ELISA, IF |
Reactivities | SARS-CoV |